Short answer
Cardinal Health (CAH) filed its fiscal 2026 10-K annual report with the SEC on Aug 11, 2026. It reported revenue of $254.2B (+14.2% year over year) and net income of $1.7B.
- Top risk flagged: DOJ Civil Investigative Demand November 2023 for potential Anti-Kickback Statute and False Claims Act violations in 2022 acquisition
FY2026 key financial metrics · XBRL
- Revenue
- $254.2B
- +14.2% YoY
- Net income
- $1.7B
- +9.8% YoY
- Operating margin
- 1.0%
- +0.0 pp YoY
- Gross margin
- 3.8%
- +0.2 pp YoY
- EPS (diluted)
- $7.23
- +12.1% YoY
- ROE
- -59.5%
- −3.3 pp YoY
- Operating cash flow
- $5.2B
- +115.9% YoY
Source: XBRL data from the Cardinal Health (CAH) FY2026 10-K on SEC EDGAR. USD.
Cardinal Health FY2026 10-K analysis
AI summary of each section, grounded in the filing text
Business Overview
- Section 'business' was empty or not found.
Management Discussion & Analysis
- Revenue $254.2B, up 14% YoY; Pharma segment up 15% to $234.8B, GMPD flat at $12.7B, Other +26% to $6.8B
- Operating margin approx. 1.03% ($2.613B / $254.2B) GAAP operating earnings up 15%, Non-GAAP margin 1.43% ($3.624B), Non-GAAP operating earnings up 30%
- Best segment: Pharma profit $2.783B up 23%; Worst: GMPD profit $258M up 91% but lowest dollar profit among segments
- Cash flow: Operating cash flow $5.2B; Capex $649M; Dividends $491M; Share repurchases $1.4B; Solaris Health acquisition $1.9B; New long-term debt net $1B; Cash and equivalents $4.9B
- Forward outlook: Management warns of tariff-related risks, regulatory uncertainties on branded pharma pricing, moderating GLP-1 demand, expects FY27 capex ~$700M, new $5B share repurchase program authorized
Risk Factors
- DOJ Civil Investigative Demand November 2023 for potential Anti-Kickback Statute and False Claims Act violations in 2022 acquisition
- $200M IEEPA tariffs paid on GMPD segment goods with $200M receivable recorded in Q4 FY26 for expected U.S. Government refund
- FDA April 2024 warning letter on plastic syringes from Chinese manufacturer lacking 510(k) clearance, requiring corrective actions
- Competitive pressure from healthcare industry consolidation risking customer loss due to greater negotiating power of combined enterprises
- IRS tax audit challenging CARES Act self-insurance losses risking $400M additional tax expense plus $1.4B liability for 2015-2020 fiscal years
Generated from the filing text; verify against the original. How to read a 10-K
Other Cardinal Health annual reports
Ask about this 10-K
Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.